The pathogenic role of autoantibodies in recurrent pregnancy loss

In the present manuscript, we review the recent research investigating the pathogenic association between most studied autoantibodies and recurrent pregnancy loss. Pregnancy loss represents a common obstetric complication occurring in about 15%‐25% of all clinically recognized pregnancies. The recur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of reproductive immunology (1989) 2020-01, Vol.83 (1), p.e13200-n/a
Hauptverfasser: D'Ippolito, Silvia, Ticconi, Carlo, Tersigni, Chiara, Garofalo, Serafina, Martino, Carmelinda, Lanzone, Antonio, Scambia, Giovanni, Di Simone, Nicoletta
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 1
container_start_page e13200
container_title American journal of reproductive immunology (1989)
container_volume 83
creator D'Ippolito, Silvia
Ticconi, Carlo
Tersigni, Chiara
Garofalo, Serafina
Martino, Carmelinda
Lanzone, Antonio
Scambia, Giovanni
Di Simone, Nicoletta
description In the present manuscript, we review the recent research investigating the pathogenic association between most studied autoantibodies and recurrent pregnancy loss. Pregnancy loss represents a common obstetric complication occurring in about 15%‐25% of all clinically recognized pregnancies. The recurrence of pregnancy loss identifies a distinct clinical entity, that is recurrent pregnancy loss (RPL), affecting about 2%‐4% of couples. Several factors, including age, chromosomal abnormalities, uterine anomalies, thrombophilic disorders, endocrinopathies, hormonal and metabolic disorders, infections, sperm quality, and lifestyle issues, are involved in RPL. The role of autoantibodies in RPL is only partially determined. In some cases (antiphospholipid antibodies [aPL]), their involvement is well established. In other cases (anti‐thyroid autoantibodies, antinuclear, anti‐transglutaminase, and anti‐endomysial antibodies), it is still debated, despite multiple, although not fully conclusive, evidences strongly suggest a possible involvement in RPL. Further extensive research is needed to definitively confirm or exclude their actual role.
doi_str_mv 10.1111/aji.13200
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2307393023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2331941211</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-802d5830a3d400a7eba89ab6dfdcaf544cb794b8dc707228147844d21daad3ea3</originalsourceid><addsrcrecordid>eNp10E1LwzAYB_AgipvTg19ACl700O3Jy5r0OIYvk4GXeS5pkm4dXTKTFtm3N9rpQTCXhPDjz_P8EbrGMMbxTOS2HmNKAE7QEGcAKYicn8Y3sCzlDMQAXYSwBYj_lJ-jAcUZpYLxIZqtNibZy3bj1sbWKvGuMYmrEtm1Ttq2Lp2uTUhqm3ijOu-NbZO9N2srrTokjQvhEp1Vsgnm6niP0Nvjw2r-nC5fnxbz2TJVdEohFUD0VFCQVDMAyU0pRS7LTFdayWrKmCp5zkqhFQdOiMCMC8Y0wVpKTY2kI3TX5-69e-9MaItdHZRpGmmN60JBKHCaUyA00ts_dOs6b-N0UVGcM0wwjuq-V8rHNbypir2vd9IfCgzFV69F7LX47jXam2NiV-6M_pU_RUYw6cFH3ZjD_0nF7GXRR34CD8CAbA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2331941211</pqid></control><display><type>article</type><title>The pathogenic role of autoantibodies in recurrent pregnancy loss</title><source>Wiley Online Library All Journals</source><creator>D'Ippolito, Silvia ; Ticconi, Carlo ; Tersigni, Chiara ; Garofalo, Serafina ; Martino, Carmelinda ; Lanzone, Antonio ; Scambia, Giovanni ; Di Simone, Nicoletta</creator><creatorcontrib>D'Ippolito, Silvia ; Ticconi, Carlo ; Tersigni, Chiara ; Garofalo, Serafina ; Martino, Carmelinda ; Lanzone, Antonio ; Scambia, Giovanni ; Di Simone, Nicoletta</creatorcontrib><description>In the present manuscript, we review the recent research investigating the pathogenic association between most studied autoantibodies and recurrent pregnancy loss. Pregnancy loss represents a common obstetric complication occurring in about 15%‐25% of all clinically recognized pregnancies. The recurrence of pregnancy loss identifies a distinct clinical entity, that is recurrent pregnancy loss (RPL), affecting about 2%‐4% of couples. Several factors, including age, chromosomal abnormalities, uterine anomalies, thrombophilic disorders, endocrinopathies, hormonal and metabolic disorders, infections, sperm quality, and lifestyle issues, are involved in RPL. The role of autoantibodies in RPL is only partially determined. In some cases (antiphospholipid antibodies [aPL]), their involvement is well established. In other cases (anti‐thyroid autoantibodies, antinuclear, anti‐transglutaminase, and anti‐endomysial antibodies), it is still debated, despite multiple, although not fully conclusive, evidences strongly suggest a possible involvement in RPL. Further extensive research is needed to definitively confirm or exclude their actual role.</description><identifier>ISSN: 1046-7408</identifier><identifier>EISSN: 1600-0897</identifier><identifier>DOI: 10.1111/aji.13200</identifier><identifier>PMID: 31633847</identifier><language>eng</language><publisher>Denmark: Wiley Subscription Services, Inc</publisher><subject>antinuclear antibodies ; Antiphospholipid antibodies ; anti‐thyroid antibodies ; Autoantibodies ; celiac disease ; Endocrine disorders ; Metabolic disorders ; Miscarriage ; Pregnancy ; recurrent pregnancy loss ; Risk factors ; Thyroid ; Uterus</subject><ispartof>American journal of reproductive immunology (1989), 2020-01, Vol.83 (1), p.e13200-n/a</ispartof><rights>2019 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><rights>2019 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-802d5830a3d400a7eba89ab6dfdcaf544cb794b8dc707228147844d21daad3ea3</citedby><cites>FETCH-LOGICAL-c3530-802d5830a3d400a7eba89ab6dfdcaf544cb794b8dc707228147844d21daad3ea3</cites><orcidid>0000-0002-6160-0558 ; 0000-0003-1590-3942 ; 0000-0003-1273-3335</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Faji.13200$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Faji.13200$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31633847$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>D'Ippolito, Silvia</creatorcontrib><creatorcontrib>Ticconi, Carlo</creatorcontrib><creatorcontrib>Tersigni, Chiara</creatorcontrib><creatorcontrib>Garofalo, Serafina</creatorcontrib><creatorcontrib>Martino, Carmelinda</creatorcontrib><creatorcontrib>Lanzone, Antonio</creatorcontrib><creatorcontrib>Scambia, Giovanni</creatorcontrib><creatorcontrib>Di Simone, Nicoletta</creatorcontrib><title>The pathogenic role of autoantibodies in recurrent pregnancy loss</title><title>American journal of reproductive immunology (1989)</title><addtitle>Am J Reprod Immunol</addtitle><description>In the present manuscript, we review the recent research investigating the pathogenic association between most studied autoantibodies and recurrent pregnancy loss. Pregnancy loss represents a common obstetric complication occurring in about 15%‐25% of all clinically recognized pregnancies. The recurrence of pregnancy loss identifies a distinct clinical entity, that is recurrent pregnancy loss (RPL), affecting about 2%‐4% of couples. Several factors, including age, chromosomal abnormalities, uterine anomalies, thrombophilic disorders, endocrinopathies, hormonal and metabolic disorders, infections, sperm quality, and lifestyle issues, are involved in RPL. The role of autoantibodies in RPL is only partially determined. In some cases (antiphospholipid antibodies [aPL]), their involvement is well established. In other cases (anti‐thyroid autoantibodies, antinuclear, anti‐transglutaminase, and anti‐endomysial antibodies), it is still debated, despite multiple, although not fully conclusive, evidences strongly suggest a possible involvement in RPL. Further extensive research is needed to definitively confirm or exclude their actual role.</description><subject>antinuclear antibodies</subject><subject>Antiphospholipid antibodies</subject><subject>anti‐thyroid antibodies</subject><subject>Autoantibodies</subject><subject>celiac disease</subject><subject>Endocrine disorders</subject><subject>Metabolic disorders</subject><subject>Miscarriage</subject><subject>Pregnancy</subject><subject>recurrent pregnancy loss</subject><subject>Risk factors</subject><subject>Thyroid</subject><subject>Uterus</subject><issn>1046-7408</issn><issn>1600-0897</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp10E1LwzAYB_AgipvTg19ACl700O3Jy5r0OIYvk4GXeS5pkm4dXTKTFtm3N9rpQTCXhPDjz_P8EbrGMMbxTOS2HmNKAE7QEGcAKYicn8Y3sCzlDMQAXYSwBYj_lJ-jAcUZpYLxIZqtNibZy3bj1sbWKvGuMYmrEtm1Ttq2Lp2uTUhqm3ijOu-NbZO9N2srrTokjQvhEp1Vsgnm6niP0Nvjw2r-nC5fnxbz2TJVdEohFUD0VFCQVDMAyU0pRS7LTFdayWrKmCp5zkqhFQdOiMCMC8Y0wVpKTY2kI3TX5-69e-9MaItdHZRpGmmN60JBKHCaUyA00ts_dOs6b-N0UVGcM0wwjuq-V8rHNbypir2vd9IfCgzFV69F7LX47jXam2NiV-6M_pU_RUYw6cFH3ZjD_0nF7GXRR34CD8CAbA</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>D'Ippolito, Silvia</creator><creator>Ticconi, Carlo</creator><creator>Tersigni, Chiara</creator><creator>Garofalo, Serafina</creator><creator>Martino, Carmelinda</creator><creator>Lanzone, Antonio</creator><creator>Scambia, Giovanni</creator><creator>Di Simone, Nicoletta</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6160-0558</orcidid><orcidid>https://orcid.org/0000-0003-1590-3942</orcidid><orcidid>https://orcid.org/0000-0003-1273-3335</orcidid></search><sort><creationdate>202001</creationdate><title>The pathogenic role of autoantibodies in recurrent pregnancy loss</title><author>D'Ippolito, Silvia ; Ticconi, Carlo ; Tersigni, Chiara ; Garofalo, Serafina ; Martino, Carmelinda ; Lanzone, Antonio ; Scambia, Giovanni ; Di Simone, Nicoletta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-802d5830a3d400a7eba89ab6dfdcaf544cb794b8dc707228147844d21daad3ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>antinuclear antibodies</topic><topic>Antiphospholipid antibodies</topic><topic>anti‐thyroid antibodies</topic><topic>Autoantibodies</topic><topic>celiac disease</topic><topic>Endocrine disorders</topic><topic>Metabolic disorders</topic><topic>Miscarriage</topic><topic>Pregnancy</topic><topic>recurrent pregnancy loss</topic><topic>Risk factors</topic><topic>Thyroid</topic><topic>Uterus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>D'Ippolito, Silvia</creatorcontrib><creatorcontrib>Ticconi, Carlo</creatorcontrib><creatorcontrib>Tersigni, Chiara</creatorcontrib><creatorcontrib>Garofalo, Serafina</creatorcontrib><creatorcontrib>Martino, Carmelinda</creatorcontrib><creatorcontrib>Lanzone, Antonio</creatorcontrib><creatorcontrib>Scambia, Giovanni</creatorcontrib><creatorcontrib>Di Simone, Nicoletta</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of reproductive immunology (1989)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>D'Ippolito, Silvia</au><au>Ticconi, Carlo</au><au>Tersigni, Chiara</au><au>Garofalo, Serafina</au><au>Martino, Carmelinda</au><au>Lanzone, Antonio</au><au>Scambia, Giovanni</au><au>Di Simone, Nicoletta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The pathogenic role of autoantibodies in recurrent pregnancy loss</atitle><jtitle>American journal of reproductive immunology (1989)</jtitle><addtitle>Am J Reprod Immunol</addtitle><date>2020-01</date><risdate>2020</risdate><volume>83</volume><issue>1</issue><spage>e13200</spage><epage>n/a</epage><pages>e13200-n/a</pages><issn>1046-7408</issn><eissn>1600-0897</eissn><abstract>In the present manuscript, we review the recent research investigating the pathogenic association between most studied autoantibodies and recurrent pregnancy loss. Pregnancy loss represents a common obstetric complication occurring in about 15%‐25% of all clinically recognized pregnancies. The recurrence of pregnancy loss identifies a distinct clinical entity, that is recurrent pregnancy loss (RPL), affecting about 2%‐4% of couples. Several factors, including age, chromosomal abnormalities, uterine anomalies, thrombophilic disorders, endocrinopathies, hormonal and metabolic disorders, infections, sperm quality, and lifestyle issues, are involved in RPL. The role of autoantibodies in RPL is only partially determined. In some cases (antiphospholipid antibodies [aPL]), their involvement is well established. In other cases (anti‐thyroid autoantibodies, antinuclear, anti‐transglutaminase, and anti‐endomysial antibodies), it is still debated, despite multiple, although not fully conclusive, evidences strongly suggest a possible involvement in RPL. Further extensive research is needed to definitively confirm or exclude their actual role.</abstract><cop>Denmark</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31633847</pmid><doi>10.1111/aji.13200</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-6160-0558</orcidid><orcidid>https://orcid.org/0000-0003-1590-3942</orcidid><orcidid>https://orcid.org/0000-0003-1273-3335</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1046-7408
ispartof American journal of reproductive immunology (1989), 2020-01, Vol.83 (1), p.e13200-n/a
issn 1046-7408
1600-0897
language eng
recordid cdi_proquest_miscellaneous_2307393023
source Wiley Online Library All Journals
subjects antinuclear antibodies
Antiphospholipid antibodies
anti‐thyroid antibodies
Autoantibodies
celiac disease
Endocrine disorders
Metabolic disorders
Miscarriage
Pregnancy
recurrent pregnancy loss
Risk factors
Thyroid
Uterus
title The pathogenic role of autoantibodies in recurrent pregnancy loss
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T07%3A31%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20pathogenic%20role%20of%20autoantibodies%20in%20recurrent%20pregnancy%20loss&rft.jtitle=American%20journal%20of%20reproductive%20immunology%20(1989)&rft.au=D'Ippolito,%20Silvia&rft.date=2020-01&rft.volume=83&rft.issue=1&rft.spage=e13200&rft.epage=n/a&rft.pages=e13200-n/a&rft.issn=1046-7408&rft.eissn=1600-0897&rft_id=info:doi/10.1111/aji.13200&rft_dat=%3Cproquest_cross%3E2331941211%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2331941211&rft_id=info:pmid/31633847&rfr_iscdi=true